SCHEMBL586324

SCHEMBL586324

O=C1Nc2ccccc2/C1=C/c1ccc2c(I)n[nH]c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.52
PLK4 O00444 2/20 0.52
PLK1 P53350 2/20 0.52
RET P07949 1/20 0.52
FLT3 P36888 1/20 0.52
KDR P35968 1/20 0.52
PSEN1 P49768 1/20 0.51
PSEN2 P49810 1/20 0.51
APH1B Q8WW43 1/20 0.51
NCSTN Q92542 1/20 0.51
APH1A Q96BI3 1/20 0.51
PSENEN Q9NZ42 1/20 0.51
MAPT P10636 5/20 0.49
APP P05067 4/20 0.49
SNCA P37840 4/20 0.49
MAPK1 P28482 3/20 0.49
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
KMT2A Q03164 2/20 0.49
TDP1 Q9NUW8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL586325 1.00 PDGFRB (0.52) PDGFRBPLK4PLK1RETFLT3
SCHEMBL586326 1.00 PDGFRB (0.52) PDGFRBPLK4PLK1RETFLT3
SCHEMBL3715350 0.91 PSEN1 (0.54) PDGFRBPLK4PLK1RETFLT3
SCHEMBL3715349 0.91 PSEN1 (0.54) PDGFRBPLK4PLK1RETFLT3
SCHEMBL578251 0.86 RPS6KA3 (0.48) PDGFRBFLT3KDRMAPTAPP
SCHEMBL578252 0.86 RPS6KA3 (0.48) PDGFRBFLT3KDRMAPTAPP
SCHEMBL585636 0.83 RET (0.55) PDGFRBPLK4RETFLT3KDR
SCHEMBL585635 0.83 RET (0.55) PDGFRBPLK4RETFLT3KDR
SCHEMBL585637 0.83 RET (0.55) PDGFRBPLK4RETFLT3KDR
SCHEMBL586161 0.83 PLK4 (0.49) PDGFRBPLK4PLK1RETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556071-A1 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME University Health Network (CA) 2013-02-13 EP disclosed
EP-2556070-A1 SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'- INDOLIN]-2'-ONES University Health Network (CA) 2013-02-13 EP disclosed
EP-2417127-A1 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME University Health Network (CA) 2012-02-15 EP disclosed
WO-2011123947-A1 SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'- INDOLIN]-2'-ONES UNIVERSITY HEALTH NETWORK (CA) 2011-10-13 WO disclosed
WO-2011123946-A1 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIVERSITY HEALTH NETWORK (CA) 2011-10-13 WO disclosed
WO-2010115279-A1 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIVERSITY HEALTH NETWORK (CA) 2010-10-14 WO disclosed